{
    "ucits": true,
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Derivatives, Inverse leveraged exposure, Compounding effect, Short investment horizon",
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Securities (ETP) aiming to provide -3x the daily performance of Tesla equity, tracking an inverse leveraged index. It uses synthetic replication via derivatives (swaps) to achieve this leverage and inverse exposure. The product involves significant leverage (3x inverse), daily rebalancing causing compounding effects, and derivative counterparty and collateral risks. The recommended holding period is very short (1 day), reflecting the complexity and risk of compounding over longer periods. The product is not capital protected and carries a very high risk rating (7/7). The structure and risks (derivative use, leverage, inverse exposure, compounding) are difficult for a retail investor with basic knowledge to understand. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such features classify the product as complex. UCITS ETFs are generally non-complex, but this product is an ETP (not a UCITS ETF) and uses synthetic replication with embedded derivatives and leverage, making it complex. The presence of leverage, synthetic replication, embedded swaps, inverse exposure, and the compounding effect all contribute to complexity. Therefore, the product requires an appropriateness assessment under MiFID II and must be classified as complex."
}